英文别名4-Amino-5-fluoro-1-((2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one; Emtricitabine Impurity 19; 2-epi-(-)-EMTRICITABINE; 4-amino-5-fluoro-1-[(2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; 4-amino-5-fluoro-1-[(2S,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one; (-)-(2S,5S)-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cystosine; 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-trans)-; 5FC-(-)-alpha; (-)-(2S,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cystosine; (2S,5S)-Emtricitabine; Emtricitabine IP Impurity J; Emtricitabine – Enantiomer Impurity; Emtricitabine impurity 1/2-epi Emtricitabine